BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32632841)

  • 1. Mixed Sparsely Granulated Lactotroph and Densely Granulated Somatotroph Pituitary Neuroendocrine Tumor Expands the Spectrum of Neuroendocrine Neoplasms in Ovarian Teratomas: the Role of Pituitary Neuroendocrine Cell Lineage Biomarkers.
    Hodgson A; Pakbaz S; Shenouda C; Francis JA; Mete O
    Endocr Pathol; 2020 Sep; 31(3):315-319. PubMed ID: 32632841
    [No Abstract]   [Full Text] [Related]  

  • 2. Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages.
    Mete O; Alshaikh OM; Cintosun A; Ezzat S; Asa SL
    Endocr Pathol; 2018 Dec; 29(4):332-338. PubMed ID: 30215160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sincronous malignant struma ovarii and papillary thyroid carcinoma.
    Fernández Catalina P; Rego Iraeta A; Lorenzo Solar M; Sánchez Sobrino P
    Endocrinol Nutr; 2016; 63(7):366-7. PubMed ID: 27297016
    [No Abstract]   [Full Text] [Related]  

  • 4. Sarcomatous Transformation of a Medically Treated Lactotroph Pituitary Neuroendocrine Tumor?
    Terry M; Reis G; Horvai A; Pekmezci M; Perry A
    Endocr Pathol; 2023 Mar; 34(1):161-163. PubMed ID: 36826690
    [No Abstract]   [Full Text] [Related]  

  • 5. Pangenomic Classification of Pituitary Neuroendocrine Tumors.
    Neou M; Villa C; Armignacco R; Jouinot A; Raffin-Sanson ML; Septier A; Letourneur F; Diry S; Diedisheim M; Izac B; Gaspar C; Perlemoine K; Verjus V; Bernier M; Boulin A; Emile JF; Bertagna X; Jaffrezic F; Laloe D; Baussart B; Bertherat J; Gaillard S; Assié G
    Cancer Cell; 2020 Jan; 37(1):123-134.e5. PubMed ID: 31883967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuroimaging of Pituitary Neuroendocrine Tumors].
    Kurosaki M
    No Shinkei Geka; 2023 Jul; 51(4):634-641. PubMed ID: 37491060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multilineage Pituitary Neuroendocrine Tumors (PitNETs) Expressing PIT1 and SF1.
    Asa SL; Mete O; Riddle ND; Perry A
    Endocr Pathol; 2023 Sep; 34(3):273-278. PubMed ID: 37268858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokeratin 8/18-negative somatotroph pituitary neuroendocrine tumours (PitNETs, adenomas) show variable morphological features and do not represent a clinicopathologically distinct entity.
    Soukup J; Cesak T; Hornychova H; Manethova M; Michnova L; Netuka D; Vitovcova B; Cap J; Ryska A; Gabalec F
    Histopathology; 2021 Sep; 79(3):406-415. PubMed ID: 33738859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follicular variant papillary thyroid carcinoma arising within an ovarian teratoma.
    Ryder M; Nikiforov YE; Fagin JA
    Thyroid; 2007 Feb; 17(2):179-80. PubMed ID: 17316122
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinicopathological Analysis of Densely and Sparsely Granulated Somatotroph Tumors of Pituitary.
    Wang L; He X; Lu L; Chen L; Peng C; Shao C; Ge R
    World Neurosurg; 2024 May; 185():e713-e720. PubMed ID: 38408701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Institutional Experience of Tumor Progression to Pituitary Carcinoma in a 15-Year Cohort of 1055 Consecutive Pituitary Neuroendocrine Tumors.
    Alshaikh OM; Asa SL; Mete O; Ezzat S
    Endocr Pathol; 2019 Jun; 30(2):118-127. PubMed ID: 30706322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GATA3 immunoreactivity expands the transcription factor profile of pituitary neuroendocrine tumors.
    Mete O; Kefeli M; Çalışkan S; Asa SL
    Mod Pathol; 2019 Apr; 32(4):484-489. PubMed ID: 30390035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA Methylation Pattern in Somatotroph Pituitary Neuroendocrine Tumors.
    Kober P; Rymuza J; Baluszek S; Maksymowicz M; Nyc A; Mossakowska BJ; Zieliński G; Kunicki J; Bujko M
    Neuroendocrinology; 2024; 114(1):51-63. PubMed ID: 37699356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dedifferentiation of neuroendocrine tumor metastases: myth or reality?
    Poiană C; Neamţu MC; Avramescu ET; Carşote M; Trifănescu R; Terzea D; Neamţu OM; Dănciulescu Miulescu R
    Rom J Morphol Embryol; 2013; 54(1):201-3. PubMed ID: 23529331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silent somatotroph pituitary adenomas: an update.
    Langlois F; Woltjer R; Cetas JS; Fleseriu M
    Pituitary; 2018 Apr; 21(2):194-202. PubMed ID: 29305680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A follicular variant of papillary thyroid carcinoma in struma ovarii. Case report with unique molecular alterations.
    Celestino R; Magalhães J; Castro P; Triller M; Vinagre J; Soares P; Sobrinho-Simões M
    Histopathology; 2009 Oct; 55(4):482-7. PubMed ID: 19817905
    [No Abstract]   [Full Text] [Related]  

  • 17. [Medical Therapies in Functioning Pituitary Neuroendocrine Tumors(PitNETs)].
    Nagamine T; Fukuda I
    No Shinkei Geka; 2023 Jul; 51(4):706-715. PubMed ID: 37491068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticotroph cell pituitary adenoma within an ovarian teratoma. A new cause of Cushing's syndrome.
    Axiotis CA; Lippes HA; Merino MJ; deLanerolle NC; Stewart AF; Kinder B
    Am J Surg Pathol; 1987 Mar; 11(3):218-24. PubMed ID: 3548446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid carcinoma originating in a teratoma of the ovary.
    Ferrer J; Herrero-Zapatero A; Orille V; Llaneza P; Pérez-Rodrigo C
    Eur J Gynaecol Oncol; 1995; 16(5):396-402. PubMed ID: 8549607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary neuroendocrine tumors of ovary: A clinicopathological spectrum in a tertiary care hospital with review of literature.
    Kushwaha P; Mandal S; Mallya V; Khurana N; Ghandhi G; Singh K
    J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S623-S627. PubMed ID: 38384029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.